Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association of neurotransmitter-based polygenic scores with antidepressant treatment outcomes in patients with major depressive disorder

Biologically informed polygenic scores (PGSs) may help interpret genetic associations with treatment outcomes. Here, we computed neurotransmitter-based PGSs (NeuroPGSs) for patients with major depressive disorder (MDD) and assessed their association with SSRI treatment outcomes. By targeting genetic variants involved i...

N. Sharew, S. Clark, V. Arolt et al. · 0 citations
Open access Sep 2026

713. NEUROFILAMENT light chain in alcohol use disorder: biomarkers, genetics, and treatment response

NfL levels are elevated in AD and decrease with early abstinence and may predict DT occurrence, highlighting neuroaxonal pathology in its pathophysiology, and the potential of integrating pharmacogenetics with objective biomarker (NfL) to characterize DT phenotype and recovery in AUD is highlighted.

M.-C. Huang, Y.-L. Liu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.